November 2020 HGT Updates

HGT Update
Written By Robert Day

  1. HGT considering products for treating osteoporosis, under “Aging” category, due to elderly falls and the resulting high rate of morbidity and mortality.

  2. November 2019 - CEO Paul Hermonat attends European GT meeting in Barcelona, Spain, presents poster. This was the last external meeting before COVID-19 lockdown.

  3. June 24, 2019 Houston Gene Therapeutics LLC is founded by Dr. Paul Hermonat, PhD.

Robert Day
Previous

First Patent Issued to Leading Biotechnology Company Houston Gene Therapeutics